Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'
- PMID: 34039620
- DOI: 10.1136/annrheumdis-2021-220494
Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'
Keywords: arthritis; glucocorticoids; osteoporosis; rheumatoid.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study' by Gong and Zhang and Lin et al.Ann Rheum Dis. 2023 Jun;82(6):e143. doi: 10.1136/annrheumdis-2021-220477. Epub 2021 May 26. Ann Rheum Dis. 2023. PMID: 34039619 No abstract available.
Comment on
-
Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study.Ann Rheum Dis. 2021 Apr;80(4):423-431. doi: 10.1136/annrheumdis-2020-218758. Epub 2020 Dec 11. Ann Rheum Dis. 2021. PMID: 33310727
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical